Colonic pseudo-obstruction due to β2-microglobulin amyloidosis after long-term haemodialysis

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 8, 1998, Pages 717-720

  Bruno, Marco J ^a   Van Dorp, Wim T ^a   Ferwerda, Jaap ^a   Dekker, Willem ^a   Schut, Niels H ^a  

^a Department of Internal Medicine ^*  (Netherlands)

Author keywords

2 microglobulin; A 2M amyloidosis; Colonic pseudo obstruction; Intestinal pseudo obstruction

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; ARTICLE; CASE REPORT; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INTESTINE PSEUDOOBSTRUCTION; OGILVIE SYNDROME; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

AGED; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; COLON; COLONIC PSEUDO-OBSTRUCTION; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; RENAL DIALYSIS; TIME FACTORS;

EID: 0031876614     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Assenat H, Calemard E, Charra B, Laurent G, Terrat C. Hémodialyse, syndrome du carpal carpien et substance amyloïde. Nouv Press Med 1980; 24:1715 (letter).
2. Gejyo F, Yamada T, Odani S, Nakagawa M, Arakawa M, Kunitomo T, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 1985; 129:701-706.
3. Lutz AE, Schneider U, Ehlerding G, Frenzel H, Koch KM, Kühn K. Right ventricular cardiac failure and pulmonary hypertension in a long-term dialysis patient - unusual presentation of visceral β2-microglobulin amyloidosis. Nephrol Dial Transplant 1995; 10:555-558.
4. Linke RP, Sommer J, Ritz E, Waldherr R, Eulitz M. Amyloid kidney stones of uremic patients consist of β2-microglobulin fragments. Biochem Biophys Res Commun 1986; 136:665-671.
5. Watanabe K, Nakamura N, Kano S, Ohrake T, Hosoda Y, Saruta T. Amyloid urinary tract calculi in patients on chronic dialysis. Nephron 1989; 52:334-337.
6. Flöge J, Brandis A, Nonnast-Daniel B, Westhoff-Bleck M, Tiedow G, Linke RP. et al. Subcutaneous amyloid-tumor of β2-microglobulin origin in a long-term hemodialysis patient. Nephron 1989; 53:73-75.
7. Maher ER, Hamilton Dutoit S, Baillod RA, Sweny P, Moorhead JF. Gastrointestinal complications of dialysis related amyloidosis. BMJ 1988; 297:265-266.
8. Takahashi S, Monta T, Koda Y, Murayama H, Hirasawa Y. Gastrointestinal involvement of dialysis-related amyloidosis. Clin Nephrol 1988; 30:168-171.
9. Kyle RA, Greipp PR, Amyloidosis (AL): clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58:665-683.
10. Legge DA, Wollaeger EE, Carlson HC. Intestinal pseudo-obstruction in systemic amyloidosis. Gut 1970; 11:764-767.
11. Wald A, Kichler J, Mendelow H. Amyloidosis and chronic intestinal pseudoobstruction. Dig Dis Sci 1981; 26:462-465.
12. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 1991; 70:246-256.
13. Tada S, Iada M, Yao T, Kitamoto T, Yao T, Fujishima M. Intestinal pseudoobstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut 1993; 34:1412-1417.
14. Shinoda T, Komatsu M, Aizawa T, Shirota T, Yamada T, Ehara T. et al. Intestinal pseudo-obstruction due to dialysis amyloidosis. Clin Nephrol 1989; 32:284-289.
15. Fuchs A, Jagirdar J, Schwartz IS. Beta 2-microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis. A new type of amyloid. Am J Clin Pathol 1987; 88: 302-307.
16. Choi HH, Heller D, Picken MM, Sidhu GS, Kahn T. Infarction of intestine with massive amyloid deposits in two patients on long-term hemodialysis. Gastroenterotogy 1989; 96:230-234,
17. Ikegaya N, Kobayashi S, Hishida A, Kaneko E, Furuhashi M, Maruyama Y. Colonic dilatation due to dialysis-related amyloidosis. Am J Kidney Dis 1995; 25:807-809.
18. Borczuk A, Mannion C, Dickson D, Alt E. Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition. Modern Pathol 1995; 8:577-582
19. Gilat T, Revach M, Sohar E. Depositions of amyloid in gastrointestinal tract. Gut 1969; 10:98-104.
20. Gilat T, Spiro HM. Amyloidosis and the gut. Am J Dig Dis 1968; 13:619-633.
21. McCarthy JT, Williams AW, Johnson WJ. Serum β2-microglobulin concentration in dialysis patients: importance of intrinsic renal function. J Lab Clin Med 1994; 123:495-505.
22. Ferreira A, Ureña P, Ang KS, Simon P, Morieux C, Souberbielle J-C, et al. Relationship between serum β2-microglobulin, bone histology, and dialysis membranes in uraemic patients. Nephrol Dial Transplant 1995; 10:1701-1707.
23. Van Ypersele de Strihou C, Jadoul M, Malghem L, Maldague B, Jamart J and the Working Party on Dialysis Amyloidosis. Eflect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39:1012-1019.
24. Aogagi R, Miura Y, Ishiyama T, Maruyama Y, Hasegawa H. Influence of dialysis membranes on the development of dialysis related osteoarthropathy. Kidney Int Suppl 1993; 41:S111-S115.
25. Brunner FP, Brynger H, Ehrich JH, Fassbinder W, Geerlings W, Rizzoni G, et al. Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA Registry. Nephrol Dial Transplant 1990; 5:432-436.
26. Risler T, Braun N, Hanel KD, Kuhlman U, Skroch D, Muller GA. Do different dialysis-membranes affect β2-microglobulin kinetics during chronic hemodialysis? Int J Artif Organs 1994; 17:581-584.
27. Charra B, Calemard E, Laurant G. Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome. Blood Purif 1988; 6:117-124.
28. Jadoel M, Noël H, van Ypersele de Strihoe C. β2-M amyloidosis in a patient treated exclusively by CARD. Am J Kidney Dis 1990; 15:86-88.
29. 2 microglobulin amyloidosis in chronic renal failure. N Engl J Med 1990; 323:1070-1071.
30. 131I-β2-microglobulm. Nephron 1989; 51:444-447.
31. 131I-β2-microglobulin scintigraphy in patients with dialysis amyloidosis. Clin Nephrol 1995; 44:S14-S18.
32. 131I-β2-microglobulin. Kidney Int 1990; 38:1169-1176.
33. Flipo RM, Marchandise X, Duquesnoy B, Dumont A, Foissac-Gegoux P, Duneton O, et al. Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis. Nephrologie 1995; 16:419-425.
34. Nelson SR, Sharpstone P, Kingswood JC. Does dialysis-associated amyloidosis resolve after transplantation? Nephrol Dial Transplant 1993; 8:369-370
35. Tan SY, Hawkins PN, Pepys MB, Lavender JP, Madhoo S, Clutterbuck EJ, et al. Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int 1996; 50:282-289.
36. Muller-Schulte D, Melzer H, Mann H. Removal of β2-microglobulin using grafted affinity absorbents as therapeutic approach for the treatment of hemodialysis patients. J Chromatogr B Biomed Appl 1994; 656:135-141.
37. Vallar L, Costa PM, Teixeira A, Pfister M, Barrois R, Costa PP, et al. Immunoabsorption procedure as a potential method for the specific beta 2-microglobulin removal from plasma of patients with chronic renal failure. J Chromatogr B Biomed Appl 1995; 664:97-106.
38. Davison AM. β2-Microglobulin and amyloidosis: who is at risk? Nephrol Dial Transplant 1995; 10:48-51.